Chronic Obstructive Pulmonary Disease (COPD) Canada
COPD Canada is a non-profit educational society and patient advocacy group focused on providing support for people living with Chronic Obstructive Pulmonary Disease (COPD). Their goal is to increase national public awareness of COPD and to upgrade the information, services and support currently available to patients and their families. The group's long-range objectives include the prevention of COPD as well as enhancing the treatment of COPD through education, patient care and advocacy.
During 2017, GSK funded COPD Canada with
- $25,000 in core funding
GSK’s contributions to COPD Canada represent 8.1% of the organization’s total revenue for 2017.